Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 20Unknown 5Recruiting 4Active not recruiting 3Not yet recruiting 2Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Stage III Gynecologic Cancer 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × OTHER × Mindfulness × Clear all
NCT04072406 2024-12-30

A Self-Directed Mindfulness Meditation Intervention in Gynecologic Cancer Patients

Washington University School of Medicine

Phase NA Terminated
21 enrolled
Gynecologic

Stage III Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡